Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baer

Showing results (501-510 of 628) with videos related to

Pageof 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720Maria R Baer, Stephen L George, Michael A Caligiuri, et al.
Journal of Vacuum Science & Technology. A, Vacuum, Surfaces, and Films : an Official Journal of the American Vacuum Society|February 1, 2014
Surface characterization of nanomaterials and nanoparticles: Important needs and challenging opportunitiesDonald R Baer, Mark H Engelhard, Grant E Johnson, et al.
Plos One|November 19, 2021
Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York CityMichael J Satlin, Jason Zucker, Benjamin R Baer, et al.
Oncotarget|September 10, 2021
Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplicationMario Scarpa, Shivani Kapoor, Eric S Tvedte, et al.
Leukemia & Lymphoma|June 16, 2020
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of BaltimoreAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Acute Myelogenous LeukemiaF R Appelbaum, M R Baer, M H Carabasi, et al.
Leukemia Research|March 5, 2024
Clinical outcomes of patients with acute myeloid leukemia and cardiovascular diseaseGabriela Sanchez-Petitto, Olga G Goloubeva, Jack Masur, et al.
Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.
Blood|September 15, 1996
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaJ Jurlander, M A Caligiuri, T Ruutu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2019
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic TransplantationKeith W Pratz, Michelle A Rudek, B Douglas Smith, et al.
Pageof 63

Showing results (501-510 of 628) with videos related to

Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720Maria R Baer, Stephen L George, Michael A Caligiuri, et al.
Journal of Vacuum Science & Technology. A, Vacuum, Surfaces, and Films : an Official Journal of the American Vacuum Society|February 1, 2014
Surface characterization of nanomaterials and nanoparticles: Important needs and challenging opportunitiesDonald R Baer, Mark H Engelhard, Grant E Johnson, et al.
Plos One|November 19, 2021
Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York CityMichael J Satlin, Jason Zucker, Benjamin R Baer, et al.
Oncotarget|September 10, 2021
Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplicationMario Scarpa, Shivani Kapoor, Eric S Tvedte, et al.
Leukemia & Lymphoma|June 16, 2020
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of BaltimoreAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Acute Myelogenous LeukemiaF R Appelbaum, M R Baer, M H Carabasi, et al.
Leukemia Research|March 5, 2024
Clinical outcomes of patients with acute myeloid leukemia and cardiovascular diseaseGabriela Sanchez-Petitto, Olga G Goloubeva, Jack Masur, et al.
Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.
Blood|September 15, 1996
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaJ Jurlander, M A Caligiuri, T Ruutu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2019
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic TransplantationKeith W Pratz, Michelle A Rudek, B Douglas Smith, et al.
Pageof 63